PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
SZ-A significantly reduced HbA1c, fasting and postprandial glucose, and 24h mean blood glucose, showing comparable time in range (TIR) to canagliflozin [PMID:42014890].
Combination of premixed insulin and SZ-A was evaluated for its effect on blood glucose fluctuations using continuous glucose monitors [PMID:38027146].
Systematic review and meta-analysis conducted to evaluate the efficacy of mulberry twig alkaloids [PMID:40083380].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 39243750 (2024) — Accelerating diabetic wound healing with Ramulus Mori (Sangzhi) alkaloids via NRF2/HO-1/eNOS pathway. · Phytomedicine : international journal of phytotherapy and phytopharmacology
- 2.PMID: 39064789 (2024) — Ramulus Mori (Sangzhi) Alkaloids Alleviate Diabetic Nephropathy through Improving Gut Microbiota Disorder. · Nutrients
- 3.PMID: 37685114 (2023) — Antibacterial Effects of Ramulus mori Oligosaccharides against Streptococcus mutans. · Foods (Basel, Switzerland)
- 4.PMID: 36739921 (2023) — Ramulus Mori (Sangzhi) alkaloids tablets for diabetes mellitus: A regulatory perspective. · Fitoterapia
- 5.PMID: 40819639 (2025) — Ramulus Mori (Sangzhi) alkaloids enhance pancreatic β-Cell maturation and function by targeting the CD81/endoplasmic reticulum stress pathway.